Literature DB >> 6156046

Impaired antigen-specific suppressor cell activity in patients with systemic lupus erythematosus.

D Gladman, E Keystone, M Urowitz, D Cane, L Poplonski.   

Abstract

Antigen-specific suppressor cell activity of peripheral blood mononuclear cells was investigated in twenty-nine patients with systemic lupus erythematosus (SLE) and sixteen normal, age- and sex-matched healthy controls. Suppressor cell activity was generated by priming peripheral blood mononuclear cells with high dose antigen (ovalbumin) and adding the washed primed or control (unprimed) cells to autologous optimally stimulated target plaque-forming cell (PFC) cultures. The ability of the primed cells to interfere with an optimal ovalbumin-specific PFC response in the target cultures was used as a measure of antigen-specific suppressor cell activity. The results demonstrated reduced suppressor cell activity in the SLE patients relative to controls--46.8 +/- 3.6% vs 63 +/- 2.4% suppression respectively (P less than 0.01). Consistent with reduced suppressor cell activity was an increase in the plaque-forming cell response to ovalbumin in patients relative to controls (880 +/- 73 vs 763 +/- 102 PFC/10(6) cells respectively [P = 0.10]). No correlation was demonstrated between suppressor cell activity in SLE patients and disease activity or therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156046      PMCID: PMC1536935     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus.

Authors:  N I Abdou; A Sagawa; E Pascual; J Hebert; S Sadeghee
Journal:  Clin Immunol Immunopathol       Date:  1976-09

Review 2.  Immunoregulation and autoimmunity.

Authors:  J D Stobo; C P Loehnen
Journal:  Mayo Clin Proc       Date:  1976-08       Impact factor: 7.616

3.  Comparison of DNA binding in normal population, general hospital laboratory personnel, and personnel from laboratories studying SLE.

Authors:  R I Carr; A A Hoffmann; R J Harbeck
Journal:  J Rheumatol       Date:  1975-06       Impact factor: 4.666

Review 4.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

5.  Purification of lymphocytes and platelets by gradient centrifugation.

Authors:  R J Perper; T W Zee; M M Mickelson
Journal:  J Lab Clin Med       Date:  1968-11

Review 6.  Suppressor cells in the regulation of the immune response.

Authors:  T A Waldmann; S Broder
Journal:  Prog Clin Immunol       Date:  1977

7.  In vitro induction and measurement of hemolytic plaque forming cells in man.

Authors:  H M Dosch; E W Gelfand
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

8.  Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness.

Authors:  L Moretta; M Ferrarini; M C Mingari; A Moretta; S R Webb
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

9.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  9 in total

1.  Specific suppression of anti-DNA production in vitro.

Authors:  M R Liebling; C Wong; J Radosevich; J S Louie
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

2.  (T,G)-A-L specific immune response potential and HLA typing of Israeli patients with systemic lupus erythematosus.

Authors:  Y Shalev; Z Bentwich; D Katz; C Brautbar; E Mozes
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

3.  B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies.

Authors:  B M Jones
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

4.  Clinical evaluation of B cell and T-regulator cell function using a protein A haemolytic plaque assay.

Authors:  B M Jones
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

5.  Generation of suppressor cells in the autologous mixed lymphocyte reaction.

Authors:  P Fitzharris; R A Knight
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

6.  Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus.

Authors:  P Fitzharris; J Alcocer; H A Stephens; R A Knight; M L Snaith
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

7.  Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyte.

Authors:  G M Kammer
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

8.  Cytotoxic responses to alloantigens in systemic lupus erythematosus.

Authors:  G C Tsokos; J E Balow
Journal:  J Clin Immunol       Date:  1981-10       Impact factor: 8.317

9.  Functional analysis of the defective T cell regulation of the antigen-specific PFC response in SLE patients: differentiation of suppressor precursor cells to suppressor effector cells.

Authors:  C J Heijnen; K H Pot; L Kater; H C Kluin-Nelemans; F Uytdehaag; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.